Resources to Empower Your Advocacy
We want to empower you to be an effective advocate in your local community, your state, and at the federal level. Below, you will find important documents about our advocacy work, such as relevant legislation, regulations, public comments, and educational information on prostate cancer. ZERO will update these documents regularly to serve as a library of relevant content to support your advocacy efforts.
Prostate Cancer Research Program at the Department of Defense
ZERO has prevented a cut to the Prostate Cancer Research Program (PCRP) in five out of the last seven years. Additionally, for the last eleven years, Congress has appropriated $80 million to the PCRP. However, in the FY2017 appropriations bill, Congress increased the PCRP's funding to $90 million. We are pleased that Congress has given the PCRP its first funding increase in over a decade, and we urge Congress to maintain that level of funding in the FY2018 appropriations process.
Get Involved with the PCRP
Congressional PCRP Sign-On Letters
The U.S. Preventive Services Task Force Prostate Cancer Screening Recommendations
On April 11, 2017, the USPSTF released their draft recommendation for the prostate-specific antigen (PSA) screening, upgrading their recommendation from a "D" grade to a "C" grade. The “C” grade, while an improvement on their previous recommendations, it is still not sufficient because it means that insurance companies: 1) Do not have to cover the PSA-test and 2) Can make patients pay for all or some of the screening even if the insurance company does cover the test.
Official ZERO Correspondence
Cancer Control and Prevention Funding at the Centers for Disease Control and Prevention (CDC)
CDC Prostate Cancer Resources
Coordinating Prostate Cancer Research Activities
To ensure best use of scarce federal dollars, aggressive pursuit of promising science, and coordination to support a wide range of priority research areas, ZERO advocates for the National Cancer Institute (NCI) to convene regular, public meetings of a prostate cancer research coordinating committee.
Prostate Cancer Activities at the National Cancer Institute (NCI)